Sinterx Pharma Private Limited
About Sinterx Pharma Private Limited
Data last updated: 13 March 2026
Sinterx Pharma Private Limited is a private limited company based in Seri Lingampally, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 26 August 2021, the company has been in operation for over 5 years.
Registered with ROC Hyderabad under CIN U24299TG2021PTC154397.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors including Sruthi Medapati and Deepika Punnapu.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Seri Lingampally, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹74.65 Cr, a growth of 0% compared to the previous year.
The company has a workforce of approximately 12 employees as per the latest available data.
As per MCA filings, the company has open charges of ₹27 Cr and satisfied charges of ₹4.05 Cr on record.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressFlat No 201 Sai Acrade Plot No.18, Survey No.66/2 Raidurgam, Seri Lingampally, Telangana, India – 500032
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Sinterx Pharma Private Limited
Sinterx Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Sinterx Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Sinterx Pharma Private Limited
Sinterx Pharma Private Limited is audited by SARATH & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SARATH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Sinterx Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sinterx Pharma Private Limited
Sinterx Pharma Private Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sruthi Medapati | Director | 26 Aug 2021 | 4 Years 10 Months | Current |
| Deepika Punnapu | Director | 26 Aug 2022 | 3 Years 10 Months | Current |
| Golla Padmavathi | Director | 01 Dec 2021 | 4 Years 7 Months | Current |
Financials of Sinterx Pharma Private Limited FY 2025 filings available
Sinterx Pharma Private Limited reported revenue of ₹74.65 Cr for FY 2025.
Ten-year financial statements for Sinterx Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sinterx Pharma Private Limited
Shareholding and ownership data for Sinterx Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sinterx Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2025 | Others | ₹25 Cr | Open |
| 14 Aug 2025 | Others | ₹2 Cr | Open |
| 23 Aug 2024 | Axis Bank Limited | ₹4.05 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Sinterx Pharma Private Limited
Sinterx Pharma Private Limited has a workforce of 12 employees as of Mar 31, 2024.
Employee and EPFO history for Sinterx Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Sinterx Pharma Private Limited
GST registrations and filing compliance for Sinterx Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Sinterx Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Sinterx Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sinterx Pharma Private Limited
MSME payment history for Sinterx Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sinterx Pharma Private Limited
Corporate group structure for Sinterx Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sinterx Pharma Private Limited
MCA filings and documents for Sinterx Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Sinterx Pharma Private Limited
Frequently Asked Questions about Sinterx Pharma Private Limited
Sinterx Pharma Private Limited is an active private limited company in the pharma sector based in Seri Lingampally, Telangana, India. It was incorporated on 26 August 2021 (5+ years old) and is registered under CIN U24299TG2021PTC154397. The company has 12 employees.
Sinterx Pharma Private Limited reported revenue of ₹74.65 Cr for FY 2025 (up 0.00% YoY).
The current directors of Sinterx Pharma Private Limited are:
- Sruthi Medapati - Director
- Deepika Punnapu - Director
- Golla Padmavathi - Director
The primary industry of Sinterx Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Sinterx Pharma Private Limited can be reached at the registered office: Flat No 201 Sai Acrade Plot No.18, Survey No.662 Raidurgam, Seri Lingampally, Telangana, India – 500032.
The authorised capital is ₹10 Lakh, and the paid-up capital is ₹7.5 Lakh.